• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

作者信息

Cavuşoğlu Yüksel

出版信息

Anadolu Kardiyol Derg. 2007 Jun;7(2):217-8; author reply 218-9.

PMID:17513231
Abstract
摘要

相似文献

1
[Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].[希美加群不能替代慢性房颤的标准华法林治疗/房颤的抗血栓治疗与希美加群：它能替代华法林吗？]
Anadolu Kardiyol Derg. 2007 Jun;7(2):217-8; author reply 218-9.
2
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].[希美加群用于心房颤动的抗栓治疗：它能替代华法林吗？]
Anadolu Kardiyol Derg. 2007 Jun;7(2):214-5; author reply 218-9.
3
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].[希美加群用于心房颤动的抗栓治疗：它能替代华法林吗？]
Anadolu Kardiyol Derg. 2007 Jun;7(2):216; author reply 218-9.
4
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].[希美加群用于心房颤动的抗栓治疗：它能替代华法林吗？]
Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8.
5
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.用希美加群或华法林治疗的非瓣膜性心房颤动患者出血情况的比较：出血发生率、病死率、时间进程、出血部位及出血危险因素的评估
Arch Intern Med. 2006 Apr 24;166(8):853-9. doi: 10.1001/archinte.166.8.853.
6
Ximelagatran for stroke prevention in atrial fibrillation.希美加群用于预防心房颤动患者的中风
Expert Rev Cardiovasc Ther. 2005 Jul;3(4):551-63. doi: 10.1586/14779072.3.4.551.
7
New possibilities in anticoagulant management of atrial fibrillation.心房颤动抗凝管理的新可能性。
Rev Cardiovasc Med. 2004;5 Suppl 5:S30-8.
8
Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.心房颤动患者心力衰竭标志物的患病率以及与华法林相比，希美加群对不良和致命事件发生率的影响：SPORTIF III和V试验的报告
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):730-9. doi: 10.1016/j.ejheart.2007.01.013. Epub 2007 Mar 13.
9
Ximelagatran versus warfarin in the prevention of atrial fibrillation-related stroke: both sides of the story.希美加群与华法林预防心房颤动相关性卒中：故事的两面
Stroke. 2007 Jul;38(7):e57. doi: 10.1161/STROKEAHA.107.486969. Epub 2007 May 17.
10
Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.希美加群用于慢性心房颤动患者卒中预防的成本与效果
JAMA. 2005 Feb 9;293(6):699-706. doi: 10.1001/jama.293.6.699.